Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis

Survival Benefit of Experience of Liver Resection for Advanced Recurrent Hepatocellular Carcinoma Treated with Sorafenib: A Propensity Score Matching Analysis

Several studies have shown that liver resection (LR) confers better survival outcomes in intermediate- and advanced-stage hepatocellular carcinoma (HCC) patients. However, the postoperative recurrence rate is high, and little is known about the survival benefits of LR for recurrent HCC patients who...

Full description

Bibliographic Details
Main Authors: Kuan-Chun Hsueh, Cheng-Chun Lee, Pi-Teh Huang, Chih-Yu Liang, Shun-Fa Yang
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Current Oncology
Subjects:
advanced hepatocellular carcinoma
surgical resection
postoperative recurrence
sorafenib
survival outcome
Online Access:https://www.mdpi.com/1718-7729/30/3/243

Similar Items

Similar Items